Research

Discover the Latest on DAPA-CKD: Dapagliflozin in Patients with Chronic Kidney Disease

Reema Parmar2020-09-05T02:47:32+00:00

The full DAPA-CKD trial results will be presented and reviewed at the ESC Congress 2020, Sunday, August 30, 17:00 – 17:30 CET. Topic Renal failure and Cardiovascular Disease Chairpersons Rory Collins (Oxford, UK); Frank Ruschitzka (Zurich, Switzerland) Presentations: DAPA-CKD – Dapagliflozin in Patients with CKD: Hiddo Heerspink (Groningen, Netherlands) DAPA- CKD – Live Prime Discussion: Diederick E Grobbee (Utrecht, Netherlands) Q&A Session The...

August 20, 2020ResearchRead more...

CORONATION Registry: Contribute Data on Kidney Patients with COVID-19 from your Region

Reema Parmar2020-09-05T02:56:03+00:00

The ISN invites nephrologists to register patients affected by COVID-19 on the new  global COVID registry. The ISN collaborated with the University of Cambridge to develop CORONATION, the Coronavirus multinational observational registry, a data entry portal accessible to nephrologists worldwide to collect anonymous data on individual people with kidney disease and the COVID-19 infection. For more information, please visit...

August 14, 2020ResearchRead more...

Coming Soon: Kidney International to Publish International Consensus Definitions of Clinical Trial Outcomes for Kidney Failure

Reema Parmar2020-12-07T10:44:51+00:00

Kidney International will shortly publish the International Consensus Definitions of Clinical Trial Outcomes for Kidney Failure: 2020, developed from the 1st International Consensus Meeting on Defining Kidney Failure in Clinical Trials hosted by the ISN in Vancouver, BC, Canada, in early 2020. This is the first attempt by the international nephrology community to identify reproducible,...

August 14, 2020ResearchRead more...

Global Trials

Reema Parmar2020-09-05T03:06:52+00:00

Every month the ISN-ACT Team lists interesting new randomized controlled trials from around the world. Highlight: Early ACE-inhibition is safe in pediatric Alport’s Syndrome and may be effective See the latest trials here

July 20, 2020ResearchRead more...

The ISN-ACT Committee Releases Statement to Encourage the Inclusion of Kidney Patients in Research Activities.

Reema Parmar2020-09-05T20:48:25+00:00

The International Society of Nephrology urges all investigators and industry partners to include people with kidney diseases in research activities related to COVID-19. The ISN-ACT (Advancing Clinical Trials) Committee has released a statement on the urgent need to include patients with kidney diseases in clinical trials related to COVID-19. Despite preliminary studies demonstrating the increased risk...

July 3, 2020ResearchRead more...

Access and Use Region-specific Results of the ISN Global Kidney Health Atlas (GKHA) 2019 during the COVID-19 Pandemic

Reema Parmar2020-09-29T14:58:58+00:00

Find key results from your region through scorecards. Available here Share the results from your region via social media or other media and press channels to support discussions on and advocate for kidney health care.

May 12, 2020News, ResearchRead more...

Looking for guidance and best practices to start your clinical trial or to participate as a trial site?

Reema Parmar2020-09-29T14:43:02+00:00

Over 5,000 people worldwide have already visited ISN's recently launched, open-access, online resource to assist you in trial design, study conduct, data management, data analysis, and publication. More than ever, clinical trials in nephrology are needed to generate high-quality evidence to inform all aspects of care for patients with or at risk of kidney disease,...

May 12, 2020News, ResearchRead more...

Access the ISN Observatory of CKDu and Share Data

Reema Parmar2020-09-29T15:15:07+00:00

In collaboration with the World Health Organization (WHO), the ISN i3C (International Consortium CKDu Collaborators) group has developed the ISN Observatory of CKDu to facilitate the exchange of information and knowledge to raise awareness of the urgent issue of Chronic Kidney Disease of unknown etiology. The input of experts in the field of CKDu provides both the ISN...

May 11, 2020News, ResearchRead more...

ISN to Launch Observatory Map on CKDu on May 7

Reema Parmar2020-09-30T09:59:35+00:00

As part of its Collaboration Plan with the World Health Organization (WHO), the ISN i3C (International Consortium CKDu Collaborators) group has developed a CKDu Observatory Map to facilitate the exchange of information and knowledge in order to raise awareness of the urgent issue of Chronic Kidney Disease of unknown etiology. Be the first to access...

May 4, 2020News, ResearchRead more...

Access and Present Region-specific Slides based on the ISN Global Kidney Health Atlas (GKHA) 2019

Reema Parmar2020-10-02T11:30:38+00:00

The ISN Global Kidney Health Atlas team has prepared summary slides of the ISN GKHA 2019 focusing on each ISN region individually. ISN invites members to share the results from their region with colleagues and key stakeholders to support discussions on and advocate for kidney health care with relevant national and regional health/policy/education officials. The new material contains...

April 30, 2020News, ResearchRead more...

Global Trials

Reema Parmar2020-10-02T12:15:18+00:00

Every month the ISN-ACT Team lists interesting new randomized controlled trials from around the world. Highlights: Keeping it simple with restriction: fluid restriction as good as diuretics and oral salt for SIAD Deciding HDF or HD: nothing to lose sleep over See the latest trials here.

April 16, 2020News, ResearchRead more...

ISN-H4KH Grant Awardee Publishes Research Findings

Reema Parmar2020-10-05T11:57:29+00:00

“High water intake and low urine osmolality are associated with favorable metabolic profile at a population level: low vasopressin secretion as a possible explanation” by ISN Hydration For Kidney Health (ISN-H4KH) Research Grant awardee, Sofia Enhörning, was published in the European Journal of Nutrition in February. Sofia Enhörning et al, investigated if low total water intake or high...

March 16, 2020News, ResearchRead more...

World Kidney Day 2020: The onset and progression of CKD are often preventable

Reema Parmar2020-10-05T12:06:17+00:00

Prof. Philip KT Li Honorary Professor of Medicine, Chinese University of Hong Kong and President of Hong Kong College of Physicians, and represents ISN on the WKD Joint Steering Committee   Dr. Guillermo García García Research Professor, University of Guadalajara Health Sciences Center, and Director of Nephrology, Hospital Civil de Guadalajara, Mexico, and represents IFKF on the WKD...

March 12, 2020News, ResearchRead more...

Lillian Jean Kaplan International Prize to be Awarded Annually

Reema Parmar2020-10-08T12:00:14+00:00

The Lilian Jean Kaplan International Prize for Advancement in the Understanding of Polycystic Kidney Disease (PKD) will now be awarded annually. ISN is grateful to Thomas Kaplan and the Recanati-Kaplan Foundation for their generosity in making this possible. The Lillian Jean Kaplan Prize recognizes individuals exhibiting excellence and leadership in PKD clinical or basic research that improves...

February 24, 2020News, ResearchRead more...

KI Supplements publishes papers on increasing access to integrated ESKD care worldwide

Reema Parmar2020-10-08T12:12:19+00:00

Kidney International Supplements (KIS) has published a set of papers describing the background, rationale, and action plans for developing a strategic approach to increase access to integrated end-stage kidney disease (ESKD) care worldwide over the next decade. Read this special edition here. Following March 2018's second Global Kidney Health Summit organised by the International Society of Nephrology (ISN), the primary...

February 24, 2020News, ResearchRead more...

Don’t miss the launch of the ISN Advancing Clinical Trials Toolkit at WCN20

Reema Parmar2020-10-08T09:50:41+00:00

The ISN Advancing Clinical Trials Toolkit is designed to assist in carrying out meaningful and robust clinical trials, or to become involved as a trial site, with the primary intention of improving patient care. Available online for the first time at the ISN World Congress of Nephrology (WCN), Congress delegates are invited to experience the...

February 24, 2020News, ResearchRead more...

ISN Research Collaborative Meeting and 1st International Consensus Meeting on Defining Kidney Failure in Clinical Trials

Reema Parmar2020-10-09T08:50:34+00:00

A two-day meeting was held in Vancouver, Canada, from January 31 to February 1, 2020, which brought together the ISN executive leadership, members of ISN Research groups, patients, clinicians, clinical trialists, academics, industry, and regulators to establish momentum for international collaborative work in clinical trials and research in kidney disease across the world. The meeting...

February 6, 2020News, ResearchRead more...

ISN Research Collaborative Meeting and 1st International Consensus Meeting on Defining Kidney Failure in Clinical Trials

Reema Parmar2020-10-15T13:20:47+00:00

A two-day meeting is to be held in Vancouver, Canada, from January 31 to February 1, 2020, bringing together members of ISN Research groups, patients, clinicians, clinical trialists, academics, industry, and regulators to establish momentum for international collaborative work in clinical trials and research in kidney disease across the world. The meeting will introduce current...

January 24, 2020News, ResearchRead more...

Access the latest ISN-ACT Global Trials

Reema Parmar2020-10-15T14:52:40+00:00

Every month the ISN-ACT Team lists interesting new randomized controlled trials from around the world. Highlights: Brace for it: an external support device may help fistulas to mature Getting things straight when it comes to peritoneal dialysis catheters See the latest trials here

January 21, 2020News, ResearchRead more...

Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

Reema Parmar2020-10-15T13:38:45+00:00

A multidisciplinary group of researchers and clinicians met in October 2018 to identify evidence and address controversies in potassium management providing research priorities and guidance for evaluation and management of dyskalemias in the context of kidney diseases.

January 21, 2020News, ResearchRead more...